Aflibercept AVE0005
AFLIBC06561
Phase 3 small_molecule terminated
Quick answer
Aflibercept AVE0005 for Colorectal Cancer Metastatic is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Colorectal Cancer Metastatic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated